Frazier Life Sciences Public Fund, L.P.

Holdings History for Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT)

Symbol: PHAT on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 5,985,327 shares
Security Ownership %: 8.6%

James N. Topper ownership in Phathom Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (PHAT)

04 Nov 2025 - James N. Topper has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,985,327 shares of Phathom Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (PHAT). This represents 8.6% ownership of the company. In their previous filing dated 20 Aug 2025, Frazier Life Sciences Public Fund, L.P. had reported owning 5,985,327 shares, indicating a new holding.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
James N. Topper	8.6%	0%	$70,447,299	5,985,327	0		$11.77	13D/A	01 Nov 2025	04 Nov 2025, 17:24
James N. Topper	8.6%	-56%	$51,593,519	5,985,327	-8,444,663	-59%	$8.62	13D/A	18 Aug 2025	20 Aug 2025, 17:18
James N. Topper	20%		$62,914,756	14,429,990			$4.36	13D/A	09 May 2025	13 May 2025, 16:22